These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20196171)

  • 1. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
    Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL
    Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
    Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
    Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas.
    Wunder JS; Eppert K; Burrow SR; Gokgoz N; Bell RS; Andrulis IL
    Oncogene; 1999 Jan; 18(3):783-8. PubMed ID: 9989829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
    Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
    Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
    Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
    Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
    Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
    Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.
    Reifenberger G; Ichimura K; Reifenberger J; Elkahloun AG; Meltzer PS; Collins VP
    Cancer Res; 1996 Nov; 56(22):5141-5. PubMed ID: 8912848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas.
    Grünewald I; Trautmann M; Busch A; Bauer L; Huss S; Schweinshaupt P; Vollbrecht C; Odenthal M; Quaas A; Büttner R; Meyer MF; Beutner D; Hüttenbrink KB; Wardelmann E; Stenner M; Hartmann W
    Oncotarget; 2016 Nov; 7(46):75261-75272. PubMed ID: 27662657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws.
    Lopes MA; Nikitakis NG; Ord RA; Sauk J
    Oral Oncol; 2001 Oct; 37(7):566-71. PubMed ID: 11564577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons.
    Wei G; Lonardo F; Ueda T; Kim T; Huvos AG; Healey JH; Ladanyi M
    Int J Cancer; 1999 Jan; 80(2):199-204. PubMed ID: 9935200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
    Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 12q amplification defines a subtype of extraskeletal osteosarcoma with good prognosis that is the soft tissue homologue of parosteal osteosarcoma.
    Kyriazoglou AI; Vieira J; Dimitriadis E; Arnogiannaki N; Teixeira MR; Pandis N
    Cancer Genet; 2012 Jun; 205(6):332-6. PubMed ID: 22749040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of CDK4 and MDM2 in malignant melanoma.
    Muthusamy V; Hobbs C; Nogueira C; Cordon-Cardo C; McKee PH; Chin L; Bosenberg MW
    Genes Chromosomes Cancer; 2006 May; 45(5):447-54. PubMed ID: 16419059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer.
    Simon R; Struckmann K; Schraml P; Wagner U; Forster T; Moch H; Fijan A; Bruderer J; Wilber K; Mihatsch MJ; Gasser T; Sauter G
    Oncogene; 2002 Apr; 21(16):2476-83. PubMed ID: 11971182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene amplification and tumor grading in parosteal osteosarcoma.
    Chen PC; Yen CC; Hung GY; Pan CC; Chen WM
    J Chin Med Assoc; 2019 Dec; 82(12):889-894. PubMed ID: 31634336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 and CDK4 expression in periosteal osteosarcoma.
    Righi A; Gambarotti M; Benini S; Gamberi G; Cocchi S; Picci P; Bertoni F
    Hum Pathol; 2015 Apr; 46(4):549-53. PubMed ID: 25680902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics.
    Yoshida A; Ushiku T; Motoi T; Shibata T; Beppu Y; Fukayama M; Tsuda H
    Mod Pathol; 2010 Sep; 23(9):1279-88. PubMed ID: 20601938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas.
    Berner JM; Forus A; Elkahloun A; Meltzer PS; Fodstad O; Myklebost O
    Genes Chromosomes Cancer; 1996 Dec; 17(4):254-9. PubMed ID: 8946207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours.
    Dei Tos AP; Doglioni C; Piccinin S; Sciot R; Furlanetto A; Boiocchi M; Dal Cin P; Maestro R; Fletcher CD; Tallini G
    J Pathol; 2000 Apr; 190(5):531-6. PubMed ID: 10727978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of 12q13-15 genes in parosteal osteosarcoma.
    Gamberi G; Ragazzini P; Benassi MS; Ferrari C; Sollazzo MR; Molendini L; Merli M; Magagnoli G; Ruggieri P; Balladelli A; Orlando C; Bacchini P; Pazzagli M; Picci P
    Clin Orthop Relat Res; 2000 Aug; (377):195-204. PubMed ID: 10943202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.